New study highlights connection with strawberries, cognition and mood in middle-aged, overweight adults

Improvements seen in executive cognitive control and emotional coping following strawberry consumption

2023-11-08

(Press-News.org) A new study published in Nutrients shows daily consumption of strawberries for 12 weeks reduced interference in memory and depressive symptoms among middle-aged, overweight adults with self-reported mild cognitive decline.

“Dementia is a general term that includes many different diseases, all without remedies,” says Robert Krikorian, Ph.D., principal investigator and professor in the department of psychiatry at the University of Cincinnati Academic Health Center. “It is not clear when or if effective therapy will be available; prevention and mitigation through dietary and lifestyle choices is currently the best approach we have.”

This double-blind, randomized controlled trial included five men and 25 women. One group received a strawberry powder prepared from whole fruit that had been desiccated, freeze-dried and milled. The second group received the control powder which was designed to have the same appearance, taste and carbohydrate load as the strawberry powder and contained fiber but no polyphenolic content. Daily servings of strawberry and control powder were sealed in packets for the convenience of the participants and to control daily dosage. Each packet of strawberry powder contained 13 grams, providing 36.8 milligrams anthocyanins derived from 130 grams whole fruit and equivalent to about 1 cup whole fresh strawberries. Participants were also asked to discontinue consumption of all berry fruits, juices and extracts for the duration of the study. This was done to mitigate the potential confound related to a group difference in consumption of berry products in the background diet.

“We wanted to work with a middle-aged, overweight population as dementia is a condition that is believed to develop over a period of decades. Furthermore, inflammation is likely a contributing factor related to metabolic disorders such as overweight/obesity, prediabetes and type 2 diabetes,” explains Krikorian.

Specifically, the findings show that after the 12-week intervention, participants who were given the whole fruit strawberry powder made fewer ‘intrusion errors’ during a word list learning task (e.g., remembering/repeating words not included in the learning task). This has relevance in terms of identifying cognitive decline as memory interference is not uncommon in the context of aging, especially in late life dementia. Additionally, participants who were given the whole fruit strawberry powder reported lower levels of depressive symptoms which implies improved emotional coping capabilities. “Our findings can likely be attributed to the anti-inflammatory actions of the anthocyanins found in strawberries,” added Krikorian.

In addition to providing polyphenols, strawberries are a source of many bioactive compounds. Strawberries provide100% of our daily vitamin C needs in single, 1-cup serving and contain heart-healthy nutrients like folate, potassium, fiber, phytosterols and polyphenols.

“We are excited with these findings and the future of polyphenol research,” says Chris Christian, senior vice president at the California Strawberry Commission. “The link between strawberry consumption and brain health has been well explored in both clinical and population-based studies. For example, strawberries and pelargonidin, a biochemical primarily found in strawberries, were associated with a reduced risk of Alzheimer’s dementia in studies conducted at Rush University. And, long-term observational studies, including the Health Professionals Study and the Nurses’ Health Study, found that strawberry consumers had lower rates of cognitive decline,” explains Christian.

For more information on strawberry research, please view the California Strawberry Commission’s Health Research Round-Up.

###

About California Strawberry Commission

The California Strawberry Commission represents more than 400 strawberry farmers, shippers, and processors, all working together to advance strawberry farming for the future of our land and people. Commission programs create opportunities for success through groundbreaking programs focused on workforce training, strawberry production research, and nutrition research. Through science-based information and education, it delivers the good news about sustainable farming practices that benefit the health of people, farms and communities.

END

ELSE PRESS RELEASES FROM THIS DATE:

Identifying a silicon transporter to improve the yield of rice

2023-11-08

Silicon (Si) is abundant in terrestrial environments and accounts for 0.1% to 10% of a plant’s dry weight. Certain plant species show high levels of Si accumulation, and research has identified high Si accumulation as a protective mechanism against abiotic (drought, cold, heat) and biotic stressors (living organisms). Oryza sativa (rice) can store Si to the tune of 10% of the dry weight of shoots (stem, leaves, flowers), and Si is vital for stable grain production. High degree of Si deposition is believed to mitigate against damage caused ...

The American Pediatric Society selects Dr. Glenn Flores as the recipient of the 2024 David G. Nichols Health Equity Award

2023-11-08

The American Pediatric Society (APS) is pleased to announce Glenn Flores, MD, as the 2024 David G. Nichols Health Equity Award recipient. The David G. Nichols Health Equity Award, administered by the APS and endowed by the American Board of Pediatrics (ABP) Foundation, was created to recognize demonstrated excellence in advancing child and adolescent health, well-being, and equity through quality improvement, advocacy, practice, or research. This award recognizes Dr. Flores’ outstanding contributions to advancing child and adolescent health, well-being, and equity and the ...

Device 'smells' seawater to discover, detect novel molecules

2023-11-08

Under the ocean’s surface, marine organisms are constantly releasing invisible molecules. Some of the chemical clues reveal which creatures are nearby, while others could be used someday as medications. Now, researchers in ACS Central Science report a proof-of-concept device that “sniffs” seawater, trapping dissolved compounds for analyses. The team showed that the system could easily concentrate molecules that are present in underwater caves and holds promise for drug discovery in fragile ecosystems, including coral reefs. A ...

A step to prevent opioid overdose deaths with light-activated naloxone treatment

2023-11-08

By rapidly reversing the effects of an opioid overdose, naloxone saves lives ― if it’s available at the right time. To eliminate this element of chance, researchers are exploring ways to have the medication available in the body before it’s needed. In a proof-of-concept in ACS’ Nano Letters, a team has designed injectable nanoparticles that released naloxone when triggered by blue light. In experiments with mice, this system was activated a month after injection. Since it began more than two decades ago, the opioid epidemic has taken an enormous toll on people’s lives. In 2022 ...

Systemic sclerosis-associated interstitial lung disease focus of latest clinical practice guideline

2023-11-08

In patients with systemic sclerosis (SSc), a rare connective tissue disease, interstitial lung disease contributes to 35 percent of deaths. Published recently in the American Journal of Respiratory and Critical Care Medicine, the latest American Thoracic Society Clinical Practice Guideline makes a number of recommendations. One recommendation expands antifibrotic treatment to all patients with systemic sclerosis associated with ILD (SSc-ILD), not just those with progressive disease. Watch the explainer video. Lead guidelines chair and editor, Ganesh Raghu, M.D., ATSF, noted the timeliness of the recommendations given the many immune ...

Study confirms the use of a new biomarker for predicting non-lymphocytic lesions, including germinoma, in patients with central diabetes insipidus

2023-11-08

Central diabetes insipidus (CDI), a rare condition involving the destruction or degeneration of neurons of the hypothalamic-posterior pituitary in the brain, has several likely underlying clinical causes. Patients with CDI experience excessive thirst and excessive urine production, owing to the decreased secretion of AVP. Moreover, in children and young adults with CDI, a malignant tumor known as a 'germinoma' may develop later in life. The diagnosis of these tumors is challenging, because biopsy in intracranial lesions is difficult. Lymphocytic infundibulo-neurohypophysitis (LINH) or ...

Anesthesia blocks sensation by cutting off communication within the cortex

2023-11-08

General anesthesia evokes a dual mystery: How does it disrupt consciousness, including sensory perception, and what might that say about the nature of consciousness. A new study led by researchers at The Picower Institute for Learning and Memory at MIT provides evidence in animals that consciousness depends on properly synchronized communication across the brain’s cortex and that the anesthetic drug propofol cancels sensory processing by cutting it off. In the Journal of Cognitive Neuroscience, researchers report clear evidence that in anesthetized animals, ...

Genetics of nearby healthy tissue may help catch lung cancer’s return

2023-11-08

Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center. The new study focuses on lung adenocarcinoma, a cancer that forms in alveolar epithelial cells and accounts for about a third of all lung cancers in the United States, according to the U.S. Centers for Disease Control and Prevention. Most patients are cured if tumors are surgically removed early in the disease’s progression, but residual ...

Scientists engineer potent immune cells for ‘off-the-shelf’ cancer immunotherapy

2023-11-08

UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for “off-the-shelf” cell therapy to treat challenging cancers. “Off-the-shelf” cell therapy, also known as allogenic therapy, uses immune cells derived from healthy donors instead of patients. The approach can bring cell therapies, like chimeric antigen receptor (CAR) T cell therapy, to more patients in a timelier manner, which is one of the major barriers in getting these life-saving treatments to patients. “Time is often of the essence when it comes to treating people with advanced cancers,” said Lili Yang, associate professor ...

Extracellular vesicles captured using sustainable wood celluose-based nanofiber sheets may identify and improve cancer treatment

2023-11-08

A research team in Japan, led by Nagoya University’s Akira Yokoi, has developed an innovative technique using cellulose nanofiber (CNF) sheets derived from wood cellulose to capture extracellular vesicles (EVs) from fluid samples and even organs during surgery. EVs are small structures from cancerous cells that play a crucial role in cell-to-cell communication. Extracting and analyzing EVs using this new technology has the potential to revolutionize early cancer diagnosis and open the door to personalized medicine. The researchers published their findings in Nature Communications. Cancer is notorious for its poor prognosis and in many cases goes undetected until its ...